Nrp1 is essential for immune response and identified as the co-receptor of VEGF to mediate angiogenesis (12), and Nrp2 exerts a significant role in VEGF-C/D/VEGFR-3-mediated tumor lymphangiogenesis and lymphatic metastasis (13). The gene discussed is NRP2; the disease is neoplasm.